Summit Primary Care

Summit Primary Care was paid $10.27M by Medicaid between Sep 2020 and Dec 2024, across 139 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 37% of everything it billed.

Compared with peers

Next to other Family Medicine Physician providers in Colorado

Rank by total paid#3 of 532

Median peer was paid$35K

This provider vs. median297×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	59,476	$922K
2021	149,901	$3.32M
2022	48,609	$2.20M
2023	60,588	$2.45M
2024incomplete	22,555	$1.38M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	37%	20,407	18,520	$3.76M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	18%	28,220	24,607	$1.84M
82075		3.7%	21,407	18,924	$385K
96127		3.0%	33,828	29,051	$311K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.8%	6,052	5,322	$292K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.7%	19,107	16,833	$279K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.7%	208	191	$170K
83992		<1%	5,739	4,946	$101K
80371		<1%	5,739	4,946	$91K
80345		<1%	5,739	4,946	$91K
80357		<1%	5,739	4,946	$91K
80335		<1%	5,739	4,946	$91K

127 more codes

80332		<1%	5,739	$91K
80339		<1%	5,739	$91K
80342		<1%	5,739	$91K
80372		<1%	5,739	$91K
80329		<1%	5,739	$91K
80353		<1%	5,739	$91K
80368		<1%	5,739	$91K
80348		<1%	5,739	$91K
80373		<1%	5,739	$91K
80354		<1%	5,739	$91K
80355		<1%	5,739	$91K
80361		<1%	5,739	$91K
80338		<1%	5,739	$91K
80365		<1%	5,739	$91K
80366		<1%	5,739	$91K
80362		<1%	5,739	$91K
80360		<1%	5,739	$91K
80358		<1%	5,739	$91K
80359		<1%	5,738	$91K
80369		<1%	5,738	$91K
80356		<1%	5,738	$91K
80346		<1%	5,739	$91K
80324		<1%	5,738	$91K
80323		<1%	5,735	$91K
99215	Doctor's office visit, returning patient (complex)	<1%	471	$47K
87150		<1%	207	$46K
80367		<1%	2,476	$38K
80350		<1%	2,476	$38K
80349		<1%	2,455	$38K
99204	Doctor's office visit, new patient (more involved)	<1%	312	$37K
82652		<1%	675	$23K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	190	$19K
82172		<1%	873	$16K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	1,501	$16K
82670		<1%	438	$11K
99205	Prolong outpt/office vis	<1%	58	$10K
99406		<1%	1,079	$9K
84443	Thyroid stimulating hormone (TSH)	<1%	611	$9K
84270		<1%	438	$9K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,340	$8K
83001		<1%	468	$8K
84146		<1%	438	$8K
83002		<1%	439	$7K
83090		<1%	439	$7K
87529		<1%	207	$7K
87481		<1%	207	$7K
82607		<1%	502	$7K
86800		<1%	452	$7K
82533		<1%	438	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,002	$6K
86376		<1%	451	$6K
87641		<1%	207	$6K
81025		<1%	894	$6K
82746		<1%	439	$6K
84439		<1%	748	$6K
96136		<1%	324	$6K
96130		<1%	107	$6K
84480		<1%	473	$6K
82728		<1%	444	$6K
99203	Doctor's office visit, new patient (routine)	<1%	68	$6K
87640		<1%	192	$5K
80061	Lipid panel	<1%	862	$5K
99497		<1%	214	$4K
94010		<1%	170	$4K
36415	Collection of venous blood by venipuncture	<1%	1,821	$4K
83550		<1%	439	$3K
87653		<1%	207	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	207	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	207	$3K
99401		<1%	168	$3K
83540		<1%	537	$3K
82977		<1%	450	$3K
87511		<1%	182	$3K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	182	$3K
83735		<1%	439	$3K
84144		<1%	131	$3K
83721		<1%	454	$2K
86431		<1%	410	$2K
86140		<1%	442	$2K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	57	$2K
82248		<1%	412	$2K
84550		<1%	439	$2K
84100		<1%	405	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	59	$2K
82947		<1%	418	$1K
90688		<1%	109	$1K
84403		<1%	51	$1K
83970		<1%	31	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	68	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	26	$1K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	106	$977.49
20552		<1%	31	$968.40
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	12	$796.53
80053	Comprehensive metabolic panel	<1%	177	$781.78
97802		<1%	266	$672.97
90792	Psychiatric diagnostic evaluation with medical services	<1%	25	$629.88
82627		<1%	31	$622.44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	80	$577.81
84481		<1%	31	$474.32
80305		<1%	65	$473.86
84153		<1%	22	$404.58
84460		<1%	593	$224.83
82310		<1%	592	$224.05
82565		<1%	592	$222.31
84450		<1%	593	$219.74
82247		<1%	592	$212.95
84075		<1%	592	$211.74
84436		<1%	93	$206.10
86430		<1%	31	$171.92
84520		<1%	592	$171.51
84155		<1%	593	$155.68
82962		<1%	409	$136.45
86593		<1%	31	$114.40
99173		<1%	75	$104.62
82040		<1%	601	$66.38
99408		<1%	69	$65.52
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	74	$46.70
83718		<1%	610	$16.38
84478		<1%	608	$5.74
82465		<1%	608	$4.35
82374		<1%	608	$2.05
84295		<1%	608	$2.02
84132		<1%	608	$2.00
82435		<1%	608	$1.93
99493		0%	24	$0.00
99492		0%	19	$0.00
98960		0%	72	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPASSILLA, ELIZABETH (MANAGER)